Clinical trial

Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against…

NCT00376376 · Michigan State University, Other · Completed

Key facts

NCT number NCT00376376
Title Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against Fluoroquinolone-Resistant E. Coli
Official title Urinary Bactericidal Activity of 4 Doses of Levofloxacin (250, 500, &750, and 1000 mg) Against Fluoroquinolone-Resistant E. Coli
Lead sponsor Michigan State University, Other
Collaborators PriCara, Unit of Ortho-McNeil, Inc. Industry
Status Completed
Study type Interventional
Conditions Healthy Volunteers
Intervention type Drug
Interventions levofloxacin at 250, 500, 750, and 1000 mg doses
Enrollment 10
Start date Sep 1, 2006
Completion Nov 1, 2006
First posted Sep 14, 2006
Last update posted Nov 27, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies